Back to list

The Blue Venture Fund

JB

John Banta

MD

AB

Andrew Boyd

VP

KC

Kelly Carlquist

VP

TC

Tony Chen

Associate

13 past transactions

Octave Bioscience

Series B in 2020
Octave Bioscience is an early-stage molecular diagnostics company focused on neurodegenerative diseases and conditions. The company was co-founded by Melinda Thomas and William Hagstrom in 2013. Octave Bioscience is headquartered in Menlo Park, California, United States.

Upward Health Inc.

Venture Round in 2021
Upward Health Inc., a specialty care coordination organization, partners with health plans and providers to help patients with mental illness and substance abuse disorders. The company offers home-based medical and behavioral care for individuals and coordinates with member’s caregivers, their primary care physician, and other medical and behavioral health specialists to ensure the member makes a full recovery and transitions safely back to his/her community. Upward Health Inc. was formerly known as BehaveCare Inc. and changed its name to Upward Health Inc. in July 2019. The company was incorporated in 2017 and is based in Providence, Rhode Island.

CirrusMD Inc.

Series C in 2021
CirrusMD Inc. operates a healthcare communication platform for doctors and patients in the United States. The company’s CirrusMD platform facilitates patients to send secure messages and images; schedule a video chat; access to health information; and 24/7 physician access to local doctors. It offers doctor-to-patient video chat and direct messaging through a HIPAA compliant patient profile. The company was founded in 2012 and is based in Denver, Colorado.

Onc.AI

Venture Round in 2020
Onc.AI is a software that specializes in clinical oncology, genomics, proteomics, and radiomics. The company develops a comprehensive approach to oncology diagnostics and uses deep learning to derive actionable insights into oncology treatment. It was founded in 2020 by Akshay Nanduri and Salmaan Ahmed and is based in San Carlos, California, United States.

Payfone

Series H in 2020
Payfone provides businesses with Identity Certainty - the ability to confirm that their customers are who they say they are to create easy, secure and frictionless experiences across PCs, mobile phones and tablets. They do for digital security what Uber does for hailing taxis and what Amazon does for online shopping. They make authenticating your customers easy for you and effortless for them. They're backed by leading banks, venture firms and wireless carriers, and are based in New York City.

Abacus Insights, Inc.

Series B in 2020
Abacus Insights, Inc. develops a cloud-based data integration and interoperability platform that organizes and exchanges data from various sources and formats for healthcare companies. Its data management platform as a service and analytics application ecosystem that offers healthcare data and provides integrated solutions through the collection of enterprise-wide data, both structured and unstructured. The platform also offers maintenance and support services to the clients. The company was incorporated in 2017 and is based in New York, New York. It has an additional office in Boston, Massachusetts.

Lumiata Inc.

Series B in 2021
Lumiata is transforming the healthcare enterprise through the application of AI. Bringing predictive power within reach of data science teams and business users, we’re driving predictability and precision at scale — empowering providers and payers to reduce risk and manage costs and move out of reliance on flat data into a future of insights. Lumiata machine learning tools and pre-trained models comprise a scalable platform purpose-built for healthcare. Lumiata products are built from more than 120 million patient records, in-depth clinical knowledge, and its proprietary clinical IP. Lumiata enables healthcare organizations to explore use cases such as underwriting and care management. Lumiata is proud to be backed by Khosla Ventures, Blue Venture Fund, Defy.vc, and AllegisNL Capital. Team Lumiata is distributed across Silicon Valley, Dallas, and Guadalajara, Mexico.

Sempre Health

Series B in 2021
Sempre Health, Inc. owns and operates a platform and offers behavior-based healthcare pricing to healthcare industry. The company works with health plans and pharmaceutical manufacturers to dynamically adjust a patient's co-payment based on individual adherence and behavior. It parses prescription records to predict the right price based on the patient's adherence to taking medicines in time. The company provides the patients access to their current discounts, why they got those discounts, and guidance on how to improve their health, via SMS. The company was founded in 2015 and is based in San Francisco, California.

Insightin Health

Series A in 2021
Insightin Health develops a platform that automates recommendations for preventative care for patients within healthcare systems. The company’s cloud-based convergent marketing platform allows healthcare organizations to develop a data hub for all channels both internal and external sources and allows data aggregation. The platform offers campaign automation which allows clients to create personalized and rule based content delivery in real-time; data management; and predictive approach from the dashboard which provides real-time actionable analytics. It centralizes member activities and delivers automated and personalized preventative actions for their healthcare journey. Additionally, the AI driven platform allows health plans to gain quality membership and lower churn by improving satisfaction and renewals. It serves Medicare/Medicaid, ACO, and FMO/broker/agent markets. The company was founded in 2016 and is headquartered in Gaithersburg, Maryland with an additional office in Pittsburgh, Pennsylvania.

Somatus, Inc.

Series C in 2020
Somatus is a healthcare company that partners with health plans, health systems, and nephrology, and primary care groups. It provides integrated care for patients with or at risk of developing kidney disease. Somatus' is vertically integrated clinical services and technology delay or prevent disease progression, improve quality and care coordination, and increase the use of home dialysis modalities and rates of kidney transplantation. The company is headquartered in McLean, Virginia, and founded by a team of world-class healthcare operators, successful entrepreneurs, and leading clinicians treating kidney disease.

PWNHealth

Private Equity Round in 2020
PWNHealth is a provider of lab connectivity, compliance, and patient outreach solutions. Their platform enables testing solutions for health and wellness, telemedicine, diagnostic labs, and payer markets, who use their services to facilitate quick and seamless consumer access to diagnostic testing and also to maintain compliance with state and federal regulations. Their 50-state physician network and strong technology platform enable them to process over five million diagnostic screens annually.

Oncology Analytics

Series C in 2020
Oncology Analytics, Inc. provides oncology benefits management solutions. Its oncology management services include prior authorization services; clinical decision support, physician education, and expert peer review services; oncology network evaluation and optimization consulting services; and performance reporting and analytics services. The company also provides MATIS, a clinical decision support software used with healthcare plans and providers that enhances oncology analytics evidence-based approach to the evaluation of cancer treatment and benefits management in the United States and Puerto Rico. Oncology Analytics, Inc. was founded in 2009 and is based in Atlanta, Georgia with additional location in Plantation, Florida.

Owl Insights

Venture Round in 2020
Owl Insights, Inc., is the provider of precision-guided behavioral care management technology for behavioral health. Through its advanced platform, affectionately termed “The Owl,” the company offers a scalable strategy to integrate measurement-based care and clinical analytics into existing behavioral health treatment workflows covering all major behavioral health conditions. Owl Insights supports health systems and independent behavioral health organizations nationwide to expand access, improve quality care delivery, better manage costs, and support the preparation for value-based care.